GMP Intelligence · Netherlands

GMP Intelligence for Quality, Leadership & Operations

Understand GMP risk. Assess the problem. Find the right expertise.

Independent · EU GMP, Annex 1, ICH Q7 to Q10, ISO 13485

Tools calculate in your browser and submit nothing

Technicians operating an aseptic filling isolator inside a validated cleanroom
Start without a contract

Everything here is free, requires no email address, and runs entirely in your browser. Nothing you enter reaches us unless you choose to send it.

7 domains

Readiness scored across the quality system, in ten minutes

Your figures

Exposure modelled from your own numbers, method published

27 articles

Plain-English reference, cited to primary regulation

How this site works

From GMP question to action

Start with reliable GMP information. Assess your situation. Identify potential risk areas. Then find the appropriate tools, expertise or training — in that order, because the alternative is buying a solution before understanding the problem.

  1. 01

    Understand

    Start from reliable GMP information, cited to the source.

  2. 02

    Assess

    Score your own situation across the quality-system domains.

  3. 03

    Identify risk

    See which areas carry the exposure, and which do not.

  4. 04

    Decide

    Sequence by exposure and by what the team can absorb.

  5. 05

    Take action

    Tools, training or expertise — after the problem is understood.

GMP Decision CenterStart from the problem rather than from the service list.

What GMP challenge are you facing?

Today's GMP IntelligenceNothing is published that is not traceable to an official source.

Regulatory and inspection intelligence

Guidance changes constantly and most summaries stop at describing the text. The useful part is the consequence for a site with a lean quality team — which is the only reason this section exists.

Regulatory changeCalendar last reviewed 2026-09-05. Not exhaustive.

What changed in GMP?

Every entry links to the authority that issued it. Nothing here is inferred or predicted — if a change is not listed, it means we have not verified it, not that it does not exist.

European Commission · Sterile manufacture · contamination control

EU GMP Annex 1 — Manufacture of Sterile Medicinal Products (revised)

Applies: 25 August 2023 (the lyophilisation provision at 8.123 applied from 25 August 2024)

The revision reorganised sterile requirements around quality risk management and a documented contamination control strategy. The most common gap is a CCS assembled by cross-referencing existing SOPs rather than written as a site-level strategy with evidence of effectiveness.

ICH · Quality risk management

ICH Q9(R1) — Quality Risk Management (revision)

Applies: Adopted by regional regulators on their own timetables

The revision sharpened subjectivity in risk scoring, the appropriate degree of formality in risk management, and how risk-based decision-making should work. If your risk assessments are scored by a group that already knows the desired answer, this is the text that addresses it.

ICH · Continuous manufacturing

ICH Q13 — Continuous Manufacturing of Drug Substances and Drug Products

Relevant only to sites operating or considering continuous manufacturing. Where it applies, control strategy and process validation expectations differ materially from batch manufacture.

GMP Health IndexEducational risk triage — not an audit, not a certification, not a regulatory determination.

How strong is your GMP system?

Twenty questions across seven quality-system domains, scored and mapped to a five-level maturity framework. It names the two areas carrying most of your exposure and what to do about each. It calculates in your browser, and any saved history stays on your device.

  • QMS

    Quality management system

  • Deviations

    Deviations

  • CAPA

    CAPA

  • Data integrity

    Documentation & data integrity

  • Validation

    Validation & qualification

  • Change & supplier

    Change & supplier control

  • Inspection readiness

    Inspection readiness

Assess your GMP health
Tools and assessmentsAnything still in development is labelled as such — nothing here pretends to work.

Put GMP risk into perspective

Quality · COOAvailable

GMP Readiness Assessment

Twenty questions across seven quality-system domains. Returns a weighted score, a domain breakdown, and names the two areas carrying most of your exposure.

Open
QualityIn development

CAPA Maturity Assessment

Intake, investigation quality, effectiveness criteria and backlog control, scored as a maturity position rather than pass/fail.

Question set drafted; needs practitioner review before publication.

QualityIn development

Data Integrity Assessment

ALCOA+ coverage across paper, hybrid and electronic records, including audit trail review and access control.

Scoring must align to PIC/S PI 041 domains; needs review.

CFO · CEO · QualityAvailable

Cost of Inaction Model

Converts deviation volume, CAPA backlog and held batches into an annual carrying cost you can set beside a remediation budget. Every rate is an editable default and the arithmetic is published on the page.

Open
CFO · COOIn development

Deviation Cost Calculator

Cost of a single investigation by loaded hours, functions involved and recurrence probability, to support triage decisions.

Extends the cost model's investigation-labour component; no backend needed.

COO · CFOIn development

Production Downtime Calculator

Throughput and margin impact of a line stoppage or a quality hold, expressed against planned capacity.

Needs site-specific capacity and margin inputs; browser-only once specified.

One GMP problem. Multiple perspectives.The same problem, read from the chairs that actually see it differently.

CAPA, from five GMP roles

QA

Did the action remove the cause, and can we show it?

Effectiveness criteria defined before implementation, checked against real data afterwards. Where retraining recurs against similar events, the record documents a pattern rather than a set of incidents.

QC

Are laboratory events feeding the same system?

OOS and OOT outcomes should enter the CAPA system on the same terms as production events, and laboratory root causes need the same evidential standard.

Manufacturing

Is the process still generating the failure?

Where the design invites the error, a training action is a delay rather than a correction. Investigation also consumes production and engineering time, so recurrence is capacity spent twice.

QP

What does an open action mean for certification?

Where a batch is affected by an unresolved deviation, Annex 16 sets expectations and the rationale for certifying must be documented.

Regulatory

How will this read to an inspectorate?

Overdue actions are visible in your own records, and a repeat finding is treated far more seriously than a first because it shows the previous correction did not work.

TrustOfficial source on one side, our explanation on the other. Never blended.

Start with the source

GMPConsultant.nl connects practical GMP explanations with authoritative regulatory sources. Every article cites the text it rests on, and every link was checked to resolve.

ExpertiseUnderstand the problem first. Then find the right expertise.

Need specialist GMP expertise?

  • GMP consultants
  • QA specialists
  • Qualified Persons
  • GMP auditors
  • Validation specialists
  • Data integrity specialists
  • Regulatory specialists
  • Supplier quality specialists
  • GMP trainers
Where to start

Understand the GMP problem before deciding what to do

Everything here is free, needs no email address and calculates in your browser. If the honest conclusion is that you do not need outside help yet, that is a useful answer too.